Abstract:Dystrophin (DMD) gene mutations are associated with skeletal muscle diseases such as Duchenne and Becker Muscular Dystrophy (BMD) and X-linked dilated cardiomyopathy (XL-DCM). To investigate the molecular basis of DCM in a 37-year-old woman. Clinical and genetic investigations were performed. Genetic testing was performed with whole exome sequencing (WES) using the Illumina platform. According to the standard protocol, a variant found by WES was confirmed in all available members of the family by bi-directional capillary Sanger resequencing. The effect of the variant was investigated by using an in silico prediction of pathogenicity. The index case was a 37-year-old woman diagnosed with DCM at the age of 33. A germline heterozygous A>G transversion at nucleotide 10103 in the DMD gene, leading to an aspartic acid–glycine substitution at the amino acid 3368 of the DMD protein (c.10103A>G p.Asp3368Gly), was identified and confirmed by PCR-based Sanger sequencing of the exon 70. In silico prediction suggests that this variant could have a deleterious impact on protein structure and functionality (CADD = 30). The genetic analysis was extended to the first-degree relatives of the proband (mother, father, and sister) and because of the absence of the variant in both parents, the p.Asp3368Gly substitution was considered as occurring de novo. Then, the direct sequencing analysis of her 8-year-old son identified as hemizygous for the same variant. The young patient did not present any signs or symptoms attributable to DCM, but reported asthenia and presented with bilateral calf hypertrophy at clinical examination. Laboratory testing revealed increased levels of creatinine kinase (maximum value of 19,000 IU/L). We report an early presentation of dilated cardiomyopathy in a 33-year-old woman due to a de novo pathogenic variant of the dystrophin (DMD) gene (p.Asp3368Gly). Genetic identification of this variant allowed an early diagnosis of a skeletal muscle disease in her son.

Adolescent sexual and reproductive health in developing countries: an overview of trends and interventions.

[A Genotyping Study of 13 Cases of Early-Onset Charcot-Marie-Tooth Disease].

X-linked myotubular myopathy in a family of two infant siblings: A case report and review

Pathogenic deep intronic MTM1 variant activates a pseudo-exon encoding a nonsense codon resulting in severe X-linked myotubular myopathy

Neonatal X-linked myotubular myopathy with a de novo mutation: A case report and literature review

Acute Mitochondrial Myopathy with Respiratory Insufficiency and Motor Axonal Polyneuropathy.

Maternally inherited mitochondrial myopathy and myoclonic epilepsy

Potential compensatory mechanisms preserving cardiac function in myotubular myopathy

Butorphanol does not reduce the minimum alveolar concentration of halothane in dogs.

Clinical Features and In Silico Analysis

X-Linked Myotubular Myopathy and Mitochondrial Function in Muscle and Liver Samples

Cartilage, bone and tooth induction during early embryonic mouse mandibular morphogenesis using serumless, chemically-defined medium.

Bilateral Striatal Necrosis Due to Homoplasmic Mitochondrial 3697G>A Mutation Presents with Incomplete Penetrance and Sex Bias.

A De Novo Mutation in Dystrophin Causing Muscular Dystrophy in a Female Patient.

Family Occurrence of an m.3303C>T Point Mutation in the MT-TL1 Gene, Which Induces Cardiomyopathy Syndrome with/without Skeletal Muscle Myopathy

Congenital Titinopathies Linked to Mutations in TTN Metatranscript-Only Exons

Mitofusin 2 Gene Mutation Causing Early-Onset CMT2A with Different Progressive Courses

Spontaneous liberation of nitric oxide cannot account for in vitro vascular relaxation by S-nitrosothiols.

[Surgical treatment of vertigo].

Hepatitis C virus (HCV) therapies special thematic issue: call for papers.

Neonatal myofibrillar myopathy type II associated with biallelic UNC-45B gene novel mutation and perinatal myasthenia as the core phenotype: A case report